Merit Medical Corp (MMSI): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Merit Medical Systems Inc (MMSI)

The market capitalization-to-revenue ratio for Merit Medical Systems (MMSI) is increasing due to the introduction of innovative catheters and imaging systems. Business stability is supported by a streamlined supply of sterile equipment to operating rooms and the absence of geopolitical risks in global deliveries. The current 3.20 metric confirms the market valuation level, reflecting the balance between the asset's value and the company's annual turnover.

Price-to-Revenue Ratio: Merit Medical (MMSI) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Merit Medical Systems Inc (MMSI)

- stock quotes and analyst forecast:
Summary company analytics:merit.com
Mass-produced product of merit.com

Professional managers utilize fundamental filters to assess whether an asset is overbought or undervalued relative to its actual cash flows. This multiple compares the business's market value to its annual revenue, which is critical for Merit Medical Systems (MMSI) during its active acquisition of sensor developers, allowing the price-to-sales ratio chart to evaluate the effectiveness of the M&A strategy and the pace of sales scaling.

Competitors of Merit Medical Systems

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Envista Holdings Corp (NVST)|ICU Medical Inc. - Market Cap to Revenue Ratio|DENTSPLY SIRONA Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (lemaitre.com)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co. STAA|ChromaDex Corp (NAGE) - Price-to-Revenue Ratio|Market Cap to Revenue ZimVie Corp|ANGO (AngioDynamics, Inc.) - P/S Multiple|Price to Sales cerus.com CERS|Price-to-Revenue Ratio Teknova (TKNO)|MGRM (Monogram Technologies Inc.) - Market Capitalization-to-Revenue Ratio|P/S Multiple STSS (Sharps Technology)|Price-to-Revenue Coefficient InfuSystem (INFU)|UTMD: Market Cap to Revenue|KORU Medical Systems - Market Cap to Sales Volume|NYXH (Nyxoah) - Market Cap to Revenue|Microbot Medical, Inc. - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Pro-Dex Corp|Market Cap to Revenue Zentek Corp (ZTEK)|P/S Multiple ELUT|MLSS - Price to Sales|P/S Multiple NXGL (NEXGEL)|RVP: Market Cap to Revenue Ratio|Harvard Bioscience - P/S Multiple|Price-to-Revenue Coefficient Femasys Corporation FEMY|MHUA: P/S Multiple|Market Cap to Revenue Predictive Oncology Inc.|CJMB (Callan JMB Inc.) - P/S Multiple|P/S Multiple Atrion Corp.|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)